Alignment Healthcare CEO Sells 298,000 Shares for $5.03 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 06 2026
0mins
Source: Fool
- Transaction Overview: On May 11, 2026, Alignment Healthcare CEO John E. Kao sold 298,000 shares of common stock for approximately $5.03 million, which is significantly above his average sell size of 165,200 shares over the past two years, indicating a notable shift in his ownership structure.
- Ownership Structure Change: This transaction reduced Kao's indirect holdings by 16.49%, leaving him with 1,508,641 shares in the JEK Trust while maintaining a direct holding of 1,784,868 shares, reflecting his continued confidence in the company's long-term trajectory.
- Market Reaction: The weighted average sale price of $16.89 per share was slightly below the market close of $17.16 on May 11, 2026, but above the current price of $15.73 as of May 17, 2026, suggesting that Kao executed the sale under relatively favorable market conditions.
- Industry Context: Amid ongoing pressures in the Medicare Advantage sector, Alignment Healthcare must demonstrate cost discipline to sustain growth, although the increasing senior population and Medicare penetration provide a long-term market opportunity.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALHC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALHC
Wall Street analysts forecast ALHC stock price to rise
9 Analyst Rating
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 21.420
Low
18.00
Averages
21.81
High
30.00
Current: 21.420
Low
18.00
Averages
21.81
High
30.00
About ALHC
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Biotech Companies See Significant Stock Gains
- Regentis Stock Surge: Regentis Biomaterials Ltd. shares soared over 88% as the company prepares to commence European Surgeon Training for GelrinC in Q3 2026, accelerating its commercialization efforts in knee cartilage repair and enhancing its competitive edge in the market.
- Eloxx Uplisting Success: Eloxx Pharmaceuticals Inc. saw its stock rise more than 77% after uplisting to Nasdaq, with plans to issue 2.975 million shares at $11.00 each, expected to generate $66 million in revenue, supporting its clinical trials for Alport syndrome treatment.
- Alignment Healthcare Gains: Alignment Healthcare Inc. shares increased over 25% following disclosures of RSU grants to executives, with projected Q2 2026 revenues between $1.295 billion and $1.315 billion, indicating strong growth potential in the healthcare sector.
- Cartesian Strategic Licensing: Cartesian Therapeutics Inc. inked a strategic licensing deal with WestGene Biopharma to advance CAR-T therapies for autoimmune diseases, with a Phase 1 trial expected to start in 2H 2026, potentially driving innovation in this therapeutic area.
See More
John E. Kao Sells 298,000 Shares Indirectly
- Sale Overview: On May 11, 2026, John E. Kao, CEO of Alignment Healthcare, indirectly sold 298,000 shares of common stock through the JEK Trust for approximately $5.03 million, representing 8.30% of his total holdings at the time.
- Holding Status: Post-transaction, Kao retains 1,784,868 shares directly and 1,508,641 shares indirectly, indicating his continued confidence in the company's long-term trajectory despite recent reductions in his holdings.
- Market Environment Analysis: The Medicare Advantage sector is under pressure from elevated medical cost ratios, with Alignment's key challenge being to demonstrate cost discipline while scaling, particularly in risk pricing and care utilization management.
- Long-Term Outlook: Despite facing policy risks and market challenges, the growing senior population and increasing penetration of Medicare Advantage suggest a significant market opportunity for Alignment Healthcare, with Kao's combined position exceeding three million shares reflecting his optimism about the company's future.
See More
Alignment Healthcare CEO Sells 298,000 Shares for $5.03 Million
- Transaction Overview: On May 11, 2026, Alignment Healthcare CEO John E. Kao sold 298,000 shares of common stock for approximately $5.03 million, which is significantly above his average sell size of 165,200 shares over the past two years, indicating a notable shift in his ownership structure.
- Ownership Structure Change: This transaction reduced Kao's indirect holdings by 16.49%, leaving him with 1,508,641 shares in the JEK Trust while maintaining a direct holding of 1,784,868 shares, reflecting his continued confidence in the company's long-term trajectory.
- Market Reaction: The weighted average sale price of $16.89 per share was slightly below the market close of $17.16 on May 11, 2026, but above the current price of $15.73 as of May 17, 2026, suggesting that Kao executed the sale under relatively favorable market conditions.
- Industry Context: Amid ongoing pressures in the Medicare Advantage sector, Alignment Healthcare must demonstrate cost discipline to sustain growth, although the increasing senior population and Medicare penetration provide a long-term market opportunity.
See More
Alignment Healthcare Joins S&P SmallCap 600 Index
- Stock Surge: Alignment Healthcare's shares jumped 7.8% in the afternoon session, reflecting market optimism regarding its inclusion in the S&P SmallCap 600 index, which is expected to attract more investor interest.
- Index Composition Change: According to the announcement, Alignment Healthcare will replace Sun Country Airlines Holdings before trading begins on May 14, meaning its stock will be forcibly purchased by index funds and ETFs, thereby increasing demand and pushing the stock price higher.
- Market Volatility: Over the past year, Alignment Healthcare's stock has experienced 23 moves greater than 5%, indicating that while today's increase is seen as significant, the market's perception of the company's fundamentals remains unchanged.
- Long-term Performance: Since the beginning of the year, Alignment Healthcare's stock has declined by 8.8%, currently trading at $18.45, which is 22.5% below its 52-week high of $23.81, showing that investors who bought $1,000 worth of shares five years ago would now see a return of only $865.20, indicating a loss on their initial investment.
See More
Alignment Healthcare Announces Leadership Updates to Strengthen Growth Strategy
- Leadership Changes: Founder and CEO John Kao has been appointed Chairman of the Board while continuing as CEO, ensuring continuity in strategy and execution to drive long-term growth.
- Executive Appointment: Joseph Konowiecki has been named Vice Chairman and Executive Vice President of Corporate Affairs, overseeing Human Resources, Legal, and Communications, thereby enhancing leadership and execution in a complex environment.
- New President: Mark Kent joins as President of the Management Services Organization, leveraging extensive experience in value-based primary care to drive MSO performance and operational execution, supporting the company's health plan.
- Operational Leadership: Shane Hochradel has been appointed Chief Operations Officer, overseeing enterprise operations and enhancing leadership across Medicare, Medicaid, and commercial businesses, further advancing the company's growth trajectory.
See More
Alignment Healthcare Joins S&P SmallCap 600 Index
- Index Composition Change: Alignment Healthcare (ALHC) will be added to the S&P SmallCap 600 index prior to the market opening on May 14, replacing Sun Country Airlines (SNCY), reflecting market recognition and confidence in ALHC.
- Acquisition Impact: The removal of Sun Country Airlines is part of a corporate acquisition by Allegiant Travel (ALGT), highlighting the accelerating trend of consolidation in the airline industry, which may affect the market performance of related companies.
- Stock Price Reaction: ALHC's stock price gained 6.5% during pre-market trading on Tuesday, indicating a positive investor response to its inclusion in the small-cap index, which could further enhance its market recognition and liquidity.
- Market Dynamics: This index adjustment not only impacts ALHC's market position but may also influence the overall competitive landscape of the airline industry, especially against the backdrop of consolidation pressures faced by low-cost carriers.
See More
Biotech Companies See Significant Stock Gains
- Regentis Stock Surge: Regentis Biomaterials Ltd. shares soared over 88% as the company prepares to commence European Surgeon Training for GelrinC in Q3 2026, accelerating its commercialization efforts in knee cartilage repair and enhancing its competitive edge in the market.
- Eloxx Uplisting Success: Eloxx Pharmaceuticals Inc. saw its stock rise more than 77% after uplisting to Nasdaq, with plans to issue 2.975 million shares at $11.00 each, expected to generate $66 million in revenue, supporting its clinical trials for Alport syndrome treatment.
- Alignment Healthcare Gains: Alignment Healthcare Inc. shares increased over 25% following disclosures of RSU grants to executives, with projected Q2 2026 revenues between $1.295 billion and $1.315 billion, indicating strong growth potential in the healthcare sector.
- Cartesian Strategic Licensing: Cartesian Therapeutics Inc. inked a strategic licensing deal with WestGene Biopharma to advance CAR-T therapies for autoimmune diseases, with a Phase 1 trial expected to start in 2H 2026, potentially driving innovation in this therapeutic area.
See More
John E. Kao Sells 298,000 Shares Indirectly
- Sale Overview: On May 11, 2026, John E. Kao, CEO of Alignment Healthcare, indirectly sold 298,000 shares of common stock through the JEK Trust for approximately $5.03 million, representing 8.30% of his total holdings at the time.
- Holding Status: Post-transaction, Kao retains 1,784,868 shares directly and 1,508,641 shares indirectly, indicating his continued confidence in the company's long-term trajectory despite recent reductions in his holdings.
- Market Environment Analysis: The Medicare Advantage sector is under pressure from elevated medical cost ratios, with Alignment's key challenge being to demonstrate cost discipline while scaling, particularly in risk pricing and care utilization management.
- Long-Term Outlook: Despite facing policy risks and market challenges, the growing senior population and increasing penetration of Medicare Advantage suggest a significant market opportunity for Alignment Healthcare, with Kao's combined position exceeding three million shares reflecting his optimism about the company's future.
See More
Alignment Healthcare CEO Sells 298,000 Shares for $5.03 Million
- Transaction Overview: On May 11, 2026, Alignment Healthcare CEO John E. Kao sold 298,000 shares of common stock for approximately $5.03 million, which is significantly above his average sell size of 165,200 shares over the past two years, indicating a notable shift in his ownership structure.
- Ownership Structure Change: This transaction reduced Kao's indirect holdings by 16.49%, leaving him with 1,508,641 shares in the JEK Trust while maintaining a direct holding of 1,784,868 shares, reflecting his continued confidence in the company's long-term trajectory.
- Market Reaction: The weighted average sale price of $16.89 per share was slightly below the market close of $17.16 on May 11, 2026, but above the current price of $15.73 as of May 17, 2026, suggesting that Kao executed the sale under relatively favorable market conditions.
- Industry Context: Amid ongoing pressures in the Medicare Advantage sector, Alignment Healthcare must demonstrate cost discipline to sustain growth, although the increasing senior population and Medicare penetration provide a long-term market opportunity.
See More
Alignment Healthcare Joins S&P SmallCap 600 Index
- Stock Surge: Alignment Healthcare's shares jumped 7.8% in the afternoon session, reflecting market optimism regarding its inclusion in the S&P SmallCap 600 index, which is expected to attract more investor interest.
- Index Composition Change: According to the announcement, Alignment Healthcare will replace Sun Country Airlines Holdings before trading begins on May 14, meaning its stock will be forcibly purchased by index funds and ETFs, thereby increasing demand and pushing the stock price higher.
- Market Volatility: Over the past year, Alignment Healthcare's stock has experienced 23 moves greater than 5%, indicating that while today's increase is seen as significant, the market's perception of the company's fundamentals remains unchanged.
- Long-term Performance: Since the beginning of the year, Alignment Healthcare's stock has declined by 8.8%, currently trading at $18.45, which is 22.5% below its 52-week high of $23.81, showing that investors who bought $1,000 worth of shares five years ago would now see a return of only $865.20, indicating a loss on their initial investment.
See More
Alignment Healthcare Announces Leadership Updates to Strengthen Growth Strategy
- Leadership Changes: Founder and CEO John Kao has been appointed Chairman of the Board while continuing as CEO, ensuring continuity in strategy and execution to drive long-term growth.
- Executive Appointment: Joseph Konowiecki has been named Vice Chairman and Executive Vice President of Corporate Affairs, overseeing Human Resources, Legal, and Communications, thereby enhancing leadership and execution in a complex environment.
- New President: Mark Kent joins as President of the Management Services Organization, leveraging extensive experience in value-based primary care to drive MSO performance and operational execution, supporting the company's health plan.
- Operational Leadership: Shane Hochradel has been appointed Chief Operations Officer, overseeing enterprise operations and enhancing leadership across Medicare, Medicaid, and commercial businesses, further advancing the company's growth trajectory.
See More
Alignment Healthcare Joins S&P SmallCap 600 Index
- Index Composition Change: Alignment Healthcare (ALHC) will be added to the S&P SmallCap 600 index prior to the market opening on May 14, replacing Sun Country Airlines (SNCY), reflecting market recognition and confidence in ALHC.
- Acquisition Impact: The removal of Sun Country Airlines is part of a corporate acquisition by Allegiant Travel (ALGT), highlighting the accelerating trend of consolidation in the airline industry, which may affect the market performance of related companies.
- Stock Price Reaction: ALHC's stock price gained 6.5% during pre-market trading on Tuesday, indicating a positive investor response to its inclusion in the small-cap index, which could further enhance its market recognition and liquidity.
- Market Dynamics: This index adjustment not only impacts ALHC's market position but may also influence the overall competitive landscape of the airline industry, especially against the backdrop of consolidation pressures faced by low-cost carriers.
See More
